XLONLABS
Market cap166mUSD
Jan 03, Last price
38.20GBP
1D
-0.78%
1Q
-2.05%
IPO
-61.80%
Name
Life Science REIT PLC
Chart & Performance
P/E
—
P/S
670.44
EPS
—
Div Yield, %
0.10%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
20m
P
Net income
-22m
L-21.39%
CFO
8m
P
Dividend
Oct 03, 20241 GBP/sh
Profile
Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. Its objective is to provide Shareholders with an attractive level of total return. The company was founded on July 27, 2021 and is headquartered in London, the United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY |
|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | |
| Income | |||
Revenues | 19,942 -200.11% | (19,920) -345.32% | |
Cost of revenue | 17,483 | 16,103 | |
Unusual Expense (Income) | |||
NOPBT | 2,459 | (36,023) | |
NOPBT Margin | 12.33% | 180.84% | |
Operating Taxes | (146) | 146 | |
Tax Rate | |||
NOPAT | 2,605 | (36,169) | |
Net income | (21,706) -21.39% | (27,613) -456.71% | |
Dividends | (14,000) | (3,500) | |
Dividend yield | |||
Proceeds from repurchase of equity | (1,118) | ||
BB yield | |||
| Debt | |||
Debt current | 35,743 | ||
Long-term debt | 107,918 | 109,831 | |
Deferred revenue | 3,692 | ||
Other long-term liabilities | (107,918) | (109,831) | |
Net debt | 89,579 | 130,665 | |
| Cash flow | |||
Cash from operating activities | 7,615 | (1,088) | |
CAPEX | (24,034) | (7,641) | |
Cash from investing activities | (11,643) | (186,378) | |
Cash from financing activities | (27,237) | 67,110 | |
FCF | 52,937 | (275,649) | |
| Balance | |||
Cash | 14,341 | 10,606 | |
Long term investments | 3,998 | 4,303 | |
Excess cash | 17,342 | 15,905 | |
Stockholders' equity | 283,745 | 319,451 | |
Invested Capital | 393,362 | 359,738 | |
ROIC | 0.69% | ||
ROCE | 0.60% | ||
| EV | |||
Common stock shares outstanding | 350,000 | 350,000 | |
Price | |||
Market cap | |||
EV | |||
EBITDA | 2,459 | (36,023) | |
EV/EBITDA | |||
Interest | 11,070 | 3,782 | |
Interest/NOPBT | 450.18% | ||